Category: Medosis Newsroom

In a breakthrough that may reshape how Alzheimer’s disease is studied and eventually treated, researchers in the United Kingdom have successfully developed….

The U.S. Food and Drug Administration (FDA) has granted approval to Atzumi™, a dihydroergotamine mesylate (DHE) nasal powder, developed by Satsuma Pharma…..

Record-breaking temperatures across several regions this April have raised global health concerns. Parts of India and Pakistan have experienced extreme heat….

Marking a milestone in the treatment of autoimmune neuromuscular disorders, the U.S. Food and Drug Administration (FDA) has officially approved Imaavy…..

Researchers at the prestigious Indian Institute of Technology (IIT) Madras have developed an innovative, portable device for the early detection of……